Endocannabinoid-mediated retrograde modulation of synaptic transmission

Current Opinion in Neurobiology

Volumn 29, Issue , 2014, Pages 1-8

  Ohno Shosaku, Takako ^a   Kano, Masanobu ^b  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CALCIUM ION; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; LIPOPROTEIN LIPASE; NEUROTRANSMITTER; VANILLOID RECEPTOR 1; AMPA RECEPTOR; VANILLOID RECEPTOR;

HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LONG TERM DEPRESSION; MENTAL DISEASE; MENTAL STRESS; NERVE CELL PLASTICITY; NEUROMODULATION; NEUROPHYSIOLOGY; NEUROTRANSMITTER RELEASE; NONHUMAN; POSTSYNAPTIC POTENTIAL; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; RETROGRADE NERVE FIBER TRANSPORT; REVIEW; SYNAPTIC TRANSMISSION; BIOSYNTHESIS; BRAIN FUNCTION; DOWN REGULATION; ENVIRONMENTAL STRESS; SHORT TERM DEPRESSION; SIGNAL TRANSDUCTION;

EID: 84898872648     PISSN: 09594388     EISSN: 18736882     Source Type: Journal    
DOI: 10.1016/j.conb.2014.03.017     Document Type: Review

References (60)

1. Kano M., Ohno-Shosaku T., Hashimotodani Y., Uchigashima M., Watanabe M. Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 2009, 89:309-380.
2. Ohno-Shosaku T., Tanimura A., Hashimotodani Y., Kano M. Endocannabinoids and retrograde modulation of synaptic transmission. Neuroscientist 2012, 18:119-132.
3. Katona I., Freund T.F. Multiple functions of endocannabinoid signaling in the brain. Ann Rev Neurosci 2012, 35:529-558.
4. Castillo P.E., Younts T.J., Chavez A.E., Hashimotodani Y. Endocannabinoid signaling and synaptic function. Neuron 2012, 76:70-81.
5. Piomelli D. More surprises lying ahead. The endocannabinoids keep us guessing. Neuropharmacology 2014, 76 Pt B:228-234.
6. Iremonger K.J., Wamsteeker Cusulin J.I., Bains J.S. Changing the tune: plasticity and adaptation of retrograde signals. Trends Neurosci 2013, 36:471-479.
7. Uchigashima M., Yamazaki M., Yamasaki M., Tanimura A., Sakimura K., Kano M., Watanabe M. Molecular and morphological configuration for 2-arachidonoylglycerol-mediated retrograde signaling at mossy cell-granule cell synapses in the dentate gyrus. J Neurosci 2011, 31:7700-7714.
8. Tanimura A., Uchigashima M., Yamazaki M., Uesaka N., Mikuni T., Abe M., Hashimoto K., Watanabe M., Sakimura K., Kano M. Synapse type-independent degradation of the endocannabinoid 2-arachidonoylglycerol after retrograde synaptic suppression. Proc Natl Acad Sci U S A 2012, 109:12195-12200.
9. 2+ dependency for triggering retrograde endocannabinoid signal. Neuron 2005, 45:257-268.
10. 2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase Cβ4 signaling cascade in the cerebellum. J Neurosci 2005, 25:6826-6835.
11. Sugawara Y., Echigo R., Kashima K., Minami H., Watanabe M., Nishikawa Y., Muranishi M., Yoneda M., Ohno-Shosaku T. Intracellular calcium level is an important factor influencing ion channel modulations by PLC-coupled metabotropic receptors in hippocampal neurons. Brain Res 2013, 1512:9-21.
12. Hashimotodani Y., Ohno-Shosaku T., Tanimura A., Kita Y., Sano Y., Shimizu T., Di Marzo V., Kano M. Acute inhibition of diacylglycerol lipase blocks endocannabinoid-mediated retrograde signalling: Evidence for on-demand biosynthesis of 2-arachidonoylglycerol. J Physiol 2013, 591:4765-4776.
13. Tanimura A., Yamazaki M., Hashimotodani Y., Uchigashima M., Kawata S., Abe M., Kita Y., Hashimoto K., Shimizu T., Watanabe M., Sakimura K., et al. The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase α mediates retrograde suppression of synaptic transmission. Neuron 2010, 65:320-327.
14. Gao Y., Vasilyev D.V., Goncalves M.B., Howell F.V., Hobbs C., Reisenberg M., Shen R., Zhang M.Y., Strassle B.W., Lu P., Mark L., et al. Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice. J Neurosci 2010, 30:2017-2024.
15. Yoshino H., Miyamae T., Hansen G., Zambrowicz B., Flynn M., Pedicord D., Blat Y., Westphal R.S., Zaczek R., Lewis D.A., Gonzalez-Burgos G. Postsynaptic diacylglycerol lipase mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex. J Physiol 2011, 589:4857-4884.
16. Zhong P., Pan B., Gao X.P., Blankman J.L., Cravatt B.F., Liu Q.S. Genetic deletion of monoacylglycerol lipase alters endocannabinoid-mediated retrograde synaptic depression in the cerebellum. J Physiol 2011, 589:4847-4855.
17. Hashimotodani Y., Ohno-Shosaku T., Kano M. Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the hippocampus. J Neurosci 2007, 27:1211-1219.
18. Min R., Di Marzo V., Mansvelder H.D. DAG lipase involvement in depolarization-induced suppression of inhibition: does endocannabinoid biosynthesis always meet the demand?. Neuroscientist 2010, 16:608-613.
19. Alger B.E., Kim J. Supply and demand for endocannabinoids. Trends Neurosci 2011, 34:304-315.
20. Min R., Testa-Silva G., Heistek T.S., Canto C.B., Lodder J.C., Bisogno T., Di Marzo V., Brussaard A.B., Burnashev N., Mansvelder H.D. Diacylglycerol lipase is not involved in depolarization-induced suppression of inhibition at unitary inhibitory connections in mouse hippocampus. J Neurosci 2010, 30:2710-2715.
21. 2+ or by metabotropic glutamate receptors appear to arise from different pools of diacylglycerol lipase. PLoS One 2011, 6:e16305.
22. Gerdeman G.L., Ronesi J., Lovinger D.M. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat Neurosci 2002, 5:446-451.
23. Younts T.J., Chevaleyre V., Castillo P.E. CA1 pyramidal cell theta-burst firing triggers endocannabinoid-mediated long-term depression at both somatic and dendritic inhibitory synapses. J Neurosci 2013, 33:13743-13757.
24. Castillo P.E. Presynaptic LTP and LTD of excitatory and inhibitory synapses. Cold Spring Harb Perspect Biol 2012, 4:a005728.
25. Singla S., Kreitzer A.C., Malenka R.C. Mechanisms for synapse specificity during striatal long-term depression. J Neurosci 2007, 27:5260-5264.
26. Heifets B.D., Chevaleyre V., Castillo P.E. Interneuron activity controls endocannabinoid-mediated presynaptic plasticity through calcineurin. Proc Natl Acad Sci U S A 2008, 105:10250-10255.
27. Sjostrom P.J., Turrigiano G.G., Nelson S.B. Neocortical LTD via coincident activation of presynaptic NMDA and cannabinoid receptors. Neuron 2003, 39:641-654.
28. Ahumada J., Fernandez de Sevilla D., Couve A., Buno W., Fuenzalida M. Long-term depression of inhibitory synaptic transmission induced by spike-timing dependent plasticity requires coactivation of endocannabinoid and muscarinic receptors. Hippocampus 2013, 23:1439-1452.
29. 2 dopamine receptor activation facilitates endocannabinoid-mediated long-term synaptic depression of GABAergic synaptic transmission in midbrain dopamine neurons via cAMP-protein kinase A signaling. J Neurosci 2008, 28:14018-14030.
30. Chiu C.Q., Puente N., Grandes P., Castillo P.E. Dopaminergic modulation of endocannabinoid-mediated plasticity at GABAergic synapses in the prefrontal cortex. J Neurosci 2010, 30:7236-7248.
31. Lerner T.N., Kreitzer A.C. RGS4 is required for dopaminergic control of striatal LTD and susceptibility to Parkinsonian motor deficits. Neuron 2012, 73:347-359.
32. Grueter B.A., Brasnjo G., Malenka R.C. Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens. Nat Neurosci 2010, 13:1519-1525.
33. Chavez A.E., Chiu C.Q., Castillo P.E. TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus. Nat Neurosci 2010, 13:1511-1518.
34. Puente N., Cui Y., Lassalle O., Lafourcade M., Georges F., Venance L., Grandes P., Manzoni O.J. Polymodal activation of the endocannabinoid system in the extended amygdala. Nat Neurosci 2011, 14:1542-1547.
35. Khlaifia A., Farah H., Gackiere F., Tell F. Anandamide, cannabinoid type 1 receptor, and NMDA receptor activation mediate non-hebbian presynaptically expressed long-term depression at the first central synapse for visceral afferent fibers. J Neurosci 2013, 33:12627-12637.
36. Kim J., Alger B.E. Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses. Nat Neurosci 2010, 13:592-600.
37. Hill M.N., Patel S., Campolongo P., Tasker J.G., Wotjak C.T., Bains J.S. Functional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output. J Neurosci 2010, 30:14980-14986.
38. Schlosburg J.E., Blankman J.L., Long J.Z., Nomura D.K., Pan B., Kinsey S.G., Nguyen P.T., Ramesh D., Booker L., Burston J.J., Thomas E.A., et al. Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nat Neurosci 2010, 13:1113-1119.
39. Freestone P.S., Guatteo E., Piscitelli F., di Marzo V., Lipski J., Mercuri N.B. Glutamate spillover drives endocannabinoid production and inhibits GABAergic transmission in the substantia nigra pars compacta. Neuropharmacology 2013, 79C:467-475.
40. Navarrete M., Araque A. Endocannabinoids potentiate synaptic transmission through stimulation of astrocytes. Neuron 2010, 68:113-126.
41. Min R., Nevian T. Astrocyte signaling controls spike timing-dependent depression at neocortical synapses. Nat Neurosci 2012, 15:746-753.
42. Han J., Kesner P., Metna-Laurent M., Duan T., Xu L., Georges F., Koehl M., Abrous D.N., Mendizabal-Zubiaga J., Grandes P., Liu Q., et al. Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD. Cell 2012, 148:1039-1050.
43. 1 receptors regulate neuronal energy metabolism. Nat Neurosci 2012, 15:558-564.
44. Fu J., Bottegoni G., Sasso O., Bertorelli R., Rocchia W., Masetti M., Guijarro A., Lodola A., Armirotti A., Garau G., Bandiera T., et al. A catalytically silent FAAH-1 variant drives anandamide transport in neurons. Nat Neurosci 2012, 15:64-69.
45. 2 alpha/arachidonic acid signaling mediates depolarization-induced suppression of excitation in the cerebellum. PLoS One 2012, 7:e41499.
46. Wang D.J., Su L.D., Wang Y.N., Yang D., Sun C.L., Zhou L., Wang X.X., Shen Y. Long-term potentiation at cerebellar parallel fiber-purkinje cell synapses requires presynaptic and postsynaptic signaling cascades. J Neurosci 2014, 34:2355-2364.
47. Morozov Y.M., Dominguez M.H., Varela L., Shanabrough M., Koch M., Horvath T.L., Rakic P. Antibodies to cannabinoid type 1 receptor co-react with stomatin-like protein 2 in mouse brain mitochondria. Eur J Neurosci 2013, 38:2341-2348.
48. Leung K., Elmes M.W., Glaser S.T., Deutsch D.G., Kaczocha M. Role of FAAH-like anandamide transporter in anandamide inactivation. PLoS One 2013, 8:e79355.
49. Shonesy B.C., Wang X., Rose K.L., Ramikie T.S., Cavener V.S., Rentz T., Baucum A.J., Jalan-Sakrikar N., Mackie K., Winder D.G., Patel S., et al. CAMKII regulates diacylglycerol lipase-α and striatal endocannabinoid signaling. Nat Neurosci 2013, 16:456-463.
50. 1 receptors. J Neurosci 2010, 30:545-555.
51. Senst L., Bains J. Neuromodulators, stress and plasticity: A role for endocannabinoid signalling. J Exp Biol 2014, 217:102-108.
52. Wamsteeker J.I., Kuzmiski J.B., Bains J.S. Repeated stress impairs endocannabinoid signaling in the paraventricular nucleus of the hypothalamus. J Neurosci 2010, 30:11188-11196.
53. Patel S., Kingsley P.J., Mackie K., Marnett L.J., Winder D.G. Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala. Neuropsychopharmacology 2009, 34:2699-2709.
54. 1) receptor-dependent plasticity from LTD to LTP in the bed nucleus of the stria terminalis. J Neurosci 2013, 33:19657-19663.
55. Hillard C.J., Weinlander K.M., Stuhr K.L. Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence. Neuroscience 2012, 204:207-229.
56. Du H., Kwon I.K., Kim J. Neuregulin-1 impairs the long-term depression of hippocampal inhibitory synapses by facilitating the degradation of endocannabinoid 2-AG. J Neurosci 2013, 33:15022-15031.
57. Foldy C., Malenka R.C., Sudhof T.C. Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling. Neuron 2013, 78:498-509.
58. Maccarrone M., Rossi S., Bari M., De Chiara V., Rapino C., Musella A., Bernardi G., Bagni C., Centonze D. Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA. Neuropsychopharmacology 2010, 35:1500-1509.
59. Zhang L., Alger B.E. Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome. J Neurosci 2010, 30:5724-5729.
60. Jung K.M., Sepers M., Henstridge C.M., Lassalle O., Neuhofer D., Martin H., Ginger M., Frick A., DiPatrizio N.V., Mackie K., Katona I., et al. Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome. Nat Commun 2012, 3:1080.